Trial intelligence / Profile preview

Fractures and Bisphosphonates wrist fracture healing trial

2011-000988-28Phase 4Completed

Sponsor
University of Edinburgh
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in bone fracture (Fx) and impaired fracture healing (IFH) comparing Alendronic acid with Placebo (2 arms). Primary endpoint: Fracture healing at 4 weeks. Started Aug 2011; status: completed.

02

Drugs

alendronate
03

Conditions

bone fracture (Fx)impaired fracture healing (IFH)

Beyond the preview

Go deeper on 2011-000988-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000988-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call